Powered By
The FDA has warned against using BioZorb Markers due to potential adverse effects (AEs), following Hologic’s recall of all unused devices.
Patients report pain, infection, device migration, and other complications, sometimes requiring additional treatment or device removal.
Patients with implants should contact providers if symptomatic; radiation therapy risks should be discussed with providers.
Do you know why the FDA recalled the biozorb device ?
Pain two years after having a BioZorb implant during a lumpectomy is not uncommon. Persistent pain could be due to scar tissue, nerve regrowth, or post-surgery complications like Post-Mastectomy Reconstruction Syndrome (PMRS). It's important to discuss this with your doctor, as they may recommend imaging, pain management Show Full Answer
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
